上市公司路演专场

返回主日程
14:00 - 17:00
  • 上市公司路演专场
  • Listed Company Roadshow
    • 主持人
  • 孙帅 ， 花旗中国商业银行医药行业主管
  • William SUN , Healthcare Industry Head, Citi China Commercial Banking
14:00 - 14:20
  • 项目1
  • Project 1
  • 兆科眼科：聚焦眼科临床需求
  • Focus on Clinical Needs of Ophthalmology
  • 戴向荣 兆科眼科有限公司执行董事兼首席运营官
  • DAI Xiangrong , Executive Director & COO, Zhaoke Ophthalmology
14:20 - 14:40
  • 项目2
  • Project 2
  • 聚焦肺癌靶向治疗，拓展肿瘤领域创新药开发
  • Focus on Targeted Therapy for Lung Cancer, Expand the R&D of Innovative Drugs in the Field of Oncology
  • 丁师哲 贝达药业股份有限公司董事长助理兼BD副总裁
  • Kevin DING , Chairman Assistant & BD Vice President of Betta Pharmaceuticals Co., Ltd.
14:40 - 15:00
  • 项目3
  • Project 3
  • 全球核心技术平台引领下一代生物药创新
  • Advancing Next-Gen Biotherapeutic Innovation
  • 张瀚文 和铂医药企业发展负责人
  • Barclay ZHANG , Head of Corporate Development, Harbour BioMed
15:00 - 15:20
  • 项目4
  • Project 4
  • 海思科医药-多项管线有序推进，创新潜能持续释放
  • Haisco Pharmaceutical Group-Multiple Pipelines Under Development, Showing Great Innovative Potential
  • 吴楠 海思科医药集团股份有限公司集团副总经理、研发副总经理
  • WU Nan , Vice President of the Group, Vice General Manager of Research and Development, Haisco Pharmaceutical Group Co., Ltd.
15:20 - 15:40
  • 项目5
  • Project 5
  • 三生制药集团经营、研发及商业授权项目进展
  • 3Sbio Inc. : Recent Development in Financial Performance, R&D, Commercialisation and BD Projects
  • 何翔 三生制药首席财务官
  • HE Xiang , CFO of 3SBIO INC.
15:40 - 16:00
  • 项目6
  • Project 6
  • Activin-ActRII 通道:针对肥胖症的创新和极具潜力的靶点
  • Blocking Activin-ActRII Pathway：Promote Muscle Regeneration and Decrease Fat Mass
  • 吴穷远 来凯医药有限公司投资者关系负责人
  • Candice WU , IR Head of Laekna, Inc.
16:00 - 16:20
  • 项目7
  • Project 7
  • 数智化整体解决方案助力医疗机构高质量发展建设
  • The Overall Solution of Digitalization Helps Medical Institutions to Achieve High-Quality Development and Construction
  • 黄先胤 深圳迈瑞生物医疗电子股份有限公司华南区总经理
  • HUANG Xianyin , General Manager of South China Region, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
16:20 - 16:40
  • 项目8
  • Project 8
  • 天然产物药物在MAFLD的临床研究进展
  • Progress of Clinical Development of Natural Product-Based Therapy in MAFLD
  • 韩冬 君圣泰医药BD负责人
  • HAN Dong , Head of BD, HighTide Therapeutics, Inc.
16:40 - 17:00
  • 项目9
  • Project 9
  • 伴随诊断开发赋能肿瘤新药中外同步开发
  • Companion Diagnostic Development Enables The Simultaneous Development of New Oncology Drugs both Domestically and Internationally
  • 陈小云 厦门艾德生物医药科技股份有限公司BD高级经理
  • Sandy CHEN , Senior Manager of BD Department, Amoy Diagnostics Co., Ltd.